These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 33638948)
1. Integrative analysis of genomic, epigenomic and transcriptomic data identified molecular subtypes of esophageal carcinoma. Ma M; Chen Y; Chong X; Jiang F; Gao J; Shen L; Zhang C Aging (Albany NY); 2021 Feb; 13(5):6999-7019. PubMed ID: 33638948 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of prognostic markers in sarcomas base on a multi-omics analysis. Song Y; Yang K; Sun T; Tang R BMC Med Genomics; 2021 Jan; 14(1):31. PubMed ID: 33509178 [TBL] [Abstract][Full Text] [Related]
3. Multi-omics analysis at epigenomics and transcriptomics levels reveals prognostic subtypes of lung squamous cell carcinoma. Xu Y; She Y; Li Y; Li H; Jia Z; Jiang G; Liang L; Duan L Biomed Pharmacother; 2020 May; 125():109859. PubMed ID: 32036209 [TBL] [Abstract][Full Text] [Related]
4. Integrative analysis of genomic and epigenetic regulation of endometrial cancer. Zhong Q; Fan J; Chu H; Pang M; Li J; Fan Y; Liu P; Wu C; Qiao J; Li R; Hang J Aging (Albany NY); 2020 May; 12(10):9260-9274. PubMed ID: 32412912 [TBL] [Abstract][Full Text] [Related]
5. Integrated multi-omics analysis of genomics, epigenomics, and transcriptomics in ovarian carcinoma. Zheng M; Hu Y; Gou R; Wang J; Nie X; Li X; Liu Q; Liu J; Lin B Aging (Albany NY); 2019 Jun; 11(12):4198-4215. PubMed ID: 31257224 [TBL] [Abstract][Full Text] [Related]
6. Multi-omics analysis of genomics, epigenomics and transcriptomics for molecular subtypes and core genes for lung adenocarcinoma. Zhao Y; Gao Y; Xu X; Zhou J; Wang H BMC Cancer; 2021 Mar; 21(1):257. PubMed ID: 33750346 [TBL] [Abstract][Full Text] [Related]
7. Epigenomic and genomic analysis of transcriptome modulation in skin cutaneous melanoma. Chen W; Cheng P; Jiang J; Ren Y; Wu D; Xue D Aging (Albany NY); 2020 Jul; 12(13):12703-12725. PubMed ID: 32639949 [TBL] [Abstract][Full Text] [Related]
8. Multi-omics analysis based on integrated genomics, epigenomics and transcriptomics in pancreatic cancer. Kong L; Liu P; Zheng M; Xue B; Liang K; Tan X Epigenomics; 2020 Mar; 12(6):507-524. PubMed ID: 32048534 [No Abstract] [Full Text] [Related]
9. Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data. Zhong Q; Lu M; Yuan W; Cui Y; Ouyang H; Fan Y; Wang Z; Wu C; Qiao J; Hang J J Transl Med; 2021 Feb; 19(1):58. PubMed ID: 33557879 [TBL] [Abstract][Full Text] [Related]
10. High Expression of miR-206 Predicts Adverse Outcomes: A Potential Therapeutic Target for Esophageal Cancer. Du G; Zhou J; Cheng L; Ma X; Gui Y; Tan B Comb Chem High Throughput Screen; 2019; 22(9):599-611. PubMed ID: 31648633 [TBL] [Abstract][Full Text] [Related]
11. Identification of MTHFD2 as a novel prognosis biomarker in esophageal carcinoma patients based on transcriptomic data and methylation profiling. Wang J; Luo J; Sun Z; Sun F; Kong Z; Yu J Medicine (Baltimore); 2020 Sep; 99(37):e22194. PubMed ID: 32925794 [TBL] [Abstract][Full Text] [Related]
12. Integrated Analysis of Multiomics Data Identified Molecular Subtypes and Oxidative Stress-Related Prognostic Biomarkers in Glioblastoma Multiforme. Ma Y; Xi Z Oxid Med Cell Longev; 2022; 2022():9993319. PubMed ID: 36193073 [TBL] [Abstract][Full Text] [Related]
13. Integrated molecular analysis reveals complex interactions between genomic and epigenomic alterations in esophageal adenocarcinomas. Peng D; Guo Y; Chen H; Zhao S; Washington K; Hu T; Shyr Y; El-Rifai W Sci Rep; 2017 Jan; 7():40729. PubMed ID: 28102292 [TBL] [Abstract][Full Text] [Related]
14. Integrative analysis of genomic and epigenomic regulation of the transcriptome in liver cancer. Woo HG; Choi JH; Yoon S; Jee BA; Cho EJ; Lee JH; Yu SJ; Yoon JH; Yi NJ; Lee KW; Suh KS; Kim YJ Nat Commun; 2017 Oct; 8(1):839. PubMed ID: 29018224 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive data analysis of genomics, epigenomics, and transcriptomics to identify specific biomolecular markers for prostate adenocarcinoma. Ye C; Wang H; Li Z; Xia C; Yuan S; Yan R; Yang X; Ma T; Wen X; Yang D Transl Androl Urol; 2021 Jul; 10(7):3030-3045. PubMed ID: 34430406 [TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of copy number and transcriptional expression profiles in esophageal cancer to identify a novel driver gene for therapy. Dong G; Mao Q; Yu D; Zhang Y; Qiu M; Dong G; Chen Q; Xia W; Wang J; Xu L; Jiang F Sci Rep; 2017 Feb; 7():42060. PubMed ID: 28169357 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive Genomic and Epigenomic Analyses on Transcriptomic Regulation in Stomach Adenocarcinoma. Chen J; Liu W; Du J; Wang P; Wang J; Ye K Front Genet; 2021; 12():778095. PubMed ID: 35222516 [No Abstract] [Full Text] [Related]
19. Estimating gene expression from DNA methylation and copy number variation: A deep learning regression model for multi-omics integration. Seal DB; Das V; Goswami S; De RK Genomics; 2020 Jul; 112(4):2833-2841. PubMed ID: 32234433 [TBL] [Abstract][Full Text] [Related]
20. Integrative epigenomic and genomic filtering for methylation markers in hepatocellular carcinomas. Shen J; LeFave C; Sirosh I; Siegel AB; Tycko B; Santella RM BMC Med Genomics; 2015 Jun; 8():28. PubMed ID: 26059414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]